Answers are grounded in this paper and cite their sources.
RTX administration was safe and effective in patients with difficult-to-treat NS. One or 2 doses of RTX may be sufficient to deplete B cells and achieve better control of pediatric NS.
No takes yet. Share an insight, caveat, or question.
Ahn et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: